INFUSION EXPRESS FINANCES NEXT PHASE OF GROWTH

Rapidly growing intravenous drug therapy centers expanding availability fueled by spa-like patient experience and low cost site-of-care.

Kansas City, MO, October 19, 2017 - Infusion Express, one of the fastest growing intravenous drug therapy providers in the country, today announced that it has raised $13.5 million of growth capital in order to expand its offering for chronically ill patients, insurance payers, and self-insured employers seeking the highest-quality intravenous drug therapy in the most consumer friendly setting at the lowest possible cost. The round was led by McKesson Ventures and Health Velocity Capital, and included Nueterra Capital of Leawood, Kansas.

“Infusion Express’ mission from the outset, has been to create a superior experience for those patients with chronic conditions such as ALS, MS, Crohn’s Disease, rheumatoid arthritis, other autoimmune disorders and primary immune deficiencies,” said Don Peterson Founder and CEO. “Our success in Kansas City and in our first wave of expansion has encouraged us to bring our services to other communities across the U.S. This funding and the strategic value of these investors will enable us to further that mission.”

“As patients continue to redefine how and where they seek care, the Infusion Express model stands out as a leader in delivering a high quality patient experience,” said Dave Schulte, Managing Director at McKesson Ventures.  “And that experience enables higher adherence to therapy which leads to better outcomes and a growing network of satisfied patients and providers.” 

The recent round of funding follows a breakthrough year in which Infusion Express was named the 60th fastest growing company in America by Inc. Magazine and 3rd fastest growing in Kansas City by the Kansas City Business Journal. The company plans to build on that success by adding additional sites in current areas of operation, including the San Francisco Bay Area, metropolitan Chicago, and Philadelphia, and in new cities across the country.

“Health Velocity Capital is excited to partner with Infusion Express to increase convenient access to IV therapy for patients with chronic conditions,” stated Bruce Crosby, Managing Partner at Health Velocity Capital.  “Infusion Express’ consumer friendly model provides patients with a comfortable, private setting, high clinical quality, and lower costs.  The company’s rapid growth is due to favorable consumer word-of-mouth and strong physician endorsement.” 

About Infusion Express

IVX offers a new approach to IV treatments that combines extreme customer care with low-cost and efficient delivery of expensive biologics and other essential treatments. The company’s superior patient experience together with a technology-based approach to medication adherence and chronic disease management benefits payers and providers as well as patients and their families.

About McKesson Ventures

McKesson Ventures is the venture capital arm of McKesson Corporation specializing in early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape. McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a health care services and information technology company dedicated to making the business of health care run better. We work with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting. Visit www.mckessonventures.com to learn more.

About Health Velocity Capital

Health Velocity Capital has offices in San Francisco, CA, and Nashville, TN, and invests exclusively in innovative healthcare software and services companies.  The firm’s partners have more than 50 collective years of experience investing, building and managing as investors, entrepreneurs and senior executives, innovative companies that created important new healthcare markets and/or that became market leaders.  In addition to investing on behalf of institutional investors, Health Velocity invests on behalf of a number of our nation’s largest and most influential healthcare organizations and a number of current and former healthcare senior executives and leaders.  Collectively, these investors represent organizations that provide health insurance to more than 60 million Americans, operate more than 80 hospitals, provide pharmacy and PBM services to more than 75% of all Americans, and provide software and services to every major hospital in the United States.  For more information, please visit www.healthvelocitycapital.com.

About Nueterra Capital

Nueterra Capital is a healthcare-focused private equity firm that is dedicated to investing in companies that advance healthcare reform.  The company was founded to empower entrepreneurs – to equip innovative minds with the capital, resources and expertise to help drive change in the healthcare industry.  We provide advisory and back office support services to our portfolio companies, enabling them to grow and scale while focusing on improving every aspect of healthcare.  We invest in healthcare providers, services and technology companies whose business model reshapes the healthcare industry.  Nueterra Capital has offices in Leawood, KS and Nashville, TN.  To learn more, visit www.nueterra.com.